Odonate Therapeutics Inc (ODT) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Odonate Therapeutics Inc   (NASDAQ: ODT)


Odonate Therapeutics Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Odonate Therapeutics Inc's ROI in the third quarter of 2021?
Odonate Therapeutics Inc recorded a cumulative net loss of $-102 million during 12 months ending in the third quarter of 2021, resulting in a negative return on investment (ROI) of -98.38%.

Within the Healthcare sector 793 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 0 to 4324.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM -28.28 % -14.72 % 7.71 % 57.28 % 84.54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 75 89 110 141 170
Return On Investment (TTM) -98.38 % -92.98 % -98.41 % -91 % -123.16 %
ODT's Overall Ranking # 4324 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -18.62 % -3.45 % -4.89 % -4.02 % -3.24 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -102 -119 -130 -126 -178

ODT Company Profile >> Back to ODT Roi Comparisons >> See Annual ODT Return On Investment



Return On Investment ODT's Ranking
Within: No.
Industry # 388
Sector # 794
Overall # 4324

Return On Investment Statistics
High Average Low
48.87 %
-861.81 %
-13497.98 %
(Jun 30 2016)   (Sep 30 2017)







Financial Statements
Odonate Therapeutics Inc's III. Quarter Investments $ 75 Millions ODT's Balance sheet
Odonate Therapeutics Inc's III. Quarter Income $ -14 Millions Quarterly ODT's Income Statement
ODT's Income by Division See ODT's Income by Division


ODT Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 141 164 124 -1 0
Y / Y Investment Growth -14.16 % 31.8 % - - -65.97 %
Net Income in Millions -126 -112 -89 -2 -2
Y / Y Net Income Growth - - - - -
Annual Return On Investment -89.73 % -68.17 % -71.47 % - -509.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ODT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ODT's Competitors
Subscribers only: Roi for Odonate Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ODT's Customers

Other Ratios
ODT's Roa ODT's Inventory Turnover Ratio ODT's Growth Rates ODT's Dividend Statistics
ODT's Profitability Ratios ODT's Asset Turnover Ratio ODT's Dividend Growth
ODT's Roe ODT's Valuation Ratios ODT's Financial Strength Ratios ODT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI

Date modified: 2026-08-29T17:39:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.